Free Trial
OTCMKTS:TWAPF

Towa Pharmaceutical Earnings Date & Estimates

Towa Pharmaceutical logo
$25.98 0.00 (0.00%)
As of 11/6/2026

Towa Pharmaceutical is estimated to report earnings on Wednesday, November 11, 2026, after market closes.

Upcoming Earnings Announcement

Announcement Date
Time
After Market Closes

What Analysts Expect from Towa Pharmaceutical

Towa Pharmaceutical is expected to post earnings of $0.6430 per share on revenue of $450.44 million.

Consensus Estimates

Consensus EPS
$0.6430
Expected Revenue
$450.44 million

Prepare for the Earnings Call

Towa Pharmaceutical Earnings FAQ

Towa Pharmaceutical (OTCMKTS:TWAPF) is estimated to report earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Towa Pharmaceutical to post earnings of $0.6430 per share for the quarter.

The consensus revenue estimate for Towa Pharmaceutical is $450.44 million for the quarter.

Towa Pharmaceutical Earnings Headlines

What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More Towa Pharmaceutical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Towa Pharmaceutical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Towa Pharmaceutical and other key companies, straight to your email.

About Towa Pharmaceutical

Towa Pharmaceutical (OTCMKTS:TWAPF) Co., Ltd. is a Japanese pharmaceutical company focused on developing, manufacturing and selling generic medicines. Its products provide lower-cost alternatives to branded drugs and are supplied primarily to Japan’s healthcare market.

Founded in 1951, the company has built its business around a broad range of prescription medicines. Its work includes developing formulations and packaging intended to make medicines easier for patients to take and for healthcare professionals to dispense.

Towa Pharmaceutical also pursues business outside Japan through international operations and subsidiaries. Its activities include pharmaceutical development, production and sales, with a focus on generic medicines.

View Towa Pharmaceutical Profile